(2E)-1-(2,5-dimethoxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4-(4-Bromo-1H-pyrazol-1-yl)piperidine hydrochloride, 97%, 250mg

(E)-2,3-Diphenylacrylonitrile, 95.0%, 100g

(3aS,8aR)-2-(Isoquinolin-3-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 100mg

3-Bromo-5-ethoxypyridine, 95.0%, 10g

3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-1,2-dihydro-2-oxo-, 98%, 5mg

2-Mercapto-1H-benzo[d]imidazol-5-ol, 97.0%, 250mg

4,4''-Dibromo-1,1':3',1''-terphenyl>98.0%(GC)1g

(R)-1-(3-Nitro-5-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 98%, 10g

1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 6-bromo-, 97+%, 100mg

(E)-METHYL 3-(3,5-DIFLUOROPHENYL)ACRYLATE, 95.0%, 10g

(R)-1-(3-Methylpyridin-2-yl)ethanamine dihydrochloride, 97%, 250mg

tert-Butyl 5-methyl-2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride, 97%, 500mg